ncRNA basic information
ncRNA ID:
MI0000285
ncRNA Database:
miRBase
ncRNA Name:
miR-205
ncRNA Type:
miRNA
ncRNA Expression:
up-regulated
ncRNA Method:
Northern blot,RT-PCR
ncRNA Target Gene:
HER3
ncRNA Pathway:
PI3K/Akt survival pathway
Evidence (ncRNA-drug):
validated
drug basic information
Drug ID:
DB01259 (DB02584)
Drug Name:
Lapatinib
Drug Method:
In the study, we show that miR-205, down-modulated in breast tumors compared with normal breast tissue, directly targets HER3 receptor, and inhibits the activation of the downstream mediator Akt. The reintroduction of miR-205 in SKBr3 cells inhibits their clonogenic potential and increases the responsiveness to tyrosine-kinase inhibitors Gefitinib and Lapatinib, abrogating the HER3-mediated resistance and restoring a potent proapoptotic activity. Our data describe miR-205 as a new oncosuppressor gene in breast cancer, able to interfere with the proliferative pathway mediated by HER receptor family.
Drug Response:
sensitive
Cancer basic information
Cancer:
breast cancer
Tissue/Cell:
cell line (SKBr3, MCF7, HEK293)
Other information
Title:
microRNA-205 regulates HER3 in human breast cancer.
Journal:
Cancer Res
Published:
2009
PubMed ID:
19276373